DAP:ETR
Danaher Corp
170,80 €
arrow_upward
+2,37%(+3,95) 1D
1 հլս, 17:35:51 GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DAP...
Open
166,85 €
High
171,50 €
Low
165,85 €
Mkt. cap
137,11 մլրդ
Avg. vol.
765,00
Volume
365,00
52-wk high
208,30 €
52-wk low
138,20 €
No. of employees
59 հզր
Open
166,85 €
High
171,50 €
Low
165,85 €
Mkt. cap
137,11 մլրդ
Avg. vol.
765,00
Volume
365,00
52-wk high
208,30 €
52-wk low
138,20 €
No. of employees
59 հզր
News stories
From sources across the web
Simply Wall Street
·
15 րոպե առաջ
Airbnb (ABNB) Launches An AI Lab As Brian Chesky Pushes In House Tools
The Daily News | Texas' Oldest Newspaper
·
1 ժամ առաջ
Traders work on the floor of the NYSE in New York
Yahoo Finance
·
1 ժամ առաջ
Stock market today: Dow, S&P 500, Nasdaq futures slip ahead of key jobs report
Investor's Business Daily
·
3 ժամ առաջ
Nasdaq Holds Strong Despite Chip Sell-Off: AMAT, ONTO, USB In Focus
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp
AI content may include mistakes. Learn more